KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Change in Receivables (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Change in Receivables data on record, last reported at -$13.9 million in Q4 2025.

  • For Q4 2025, Change in Receivables rose 50.14% year-over-year to -$13.9 million; the TTM value through Dec 2025 reached $68.7 million, up 143.01%, while the annual FY2025 figure was $68.7 million, 143.01% up from the prior year.
  • Change in Receivables reached -$13.9 million in Q4 2025 per IDXX's latest filing, down from $7.7 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $54.7 million in Q1 2021 and bottomed at -$27.8 million in Q4 2024.
  • Average Change in Receivables over 5 years is $11.3 million, with a median of $7.0 million recorded in 2022.
  • Peak YoY movement for Change in Receivables: soared 505.16% in 2022, then plummeted 3953.5% in 2024.
  • A 5-year view of Change in Receivables shows it stood at -$15.9 million in 2021, then surged by 139.83% to $6.3 million in 2022, then plummeted by 110.83% to -$686000.0 in 2023, then tumbled by 3953.5% to -$27.8 million in 2024, then surged by 50.14% to -$13.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$13.9 million in Q4 2025, $7.7 million in Q3 2025, and $29.6 million in Q2 2025.